
Kanabo Calls in Administrators, Marking Sobering End to LSE Cannabis Rush
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis

UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis

Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after

SPECULATION that Cellular Goods was on the verge of being acquired has been swirling since early August when rumours of

Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May

CELLULAR Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, today announces the publication

THIS week has seen European cannabis stocks once again gain momentum in the face of dismal economic news. In the

CELLULAR Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce

In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting

CELLULAR Goods has released its first significant update since announcing that its ingestibles products were not legally allowed to be

THE fallout from the publication of the FSA’s Public List is continuing to be felt on the stock markets this

European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up

FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history.

The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears

On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets.

Cellular Goods today announces the release of a major new white paper, ‘Cannabinoids for the Prevention of Aging’, which explores the benefits cannabinoids, namely cannabidiol (CBD) and cannabigerol (CBG), can have for the skin by preventing the signs of aging.

CELLULAR Goods has announced that health and beauty industry veteran Anna Chokina has replaced Alexis Abraham as its new CEO

Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the

TRADE groups representing over 1,000 hemp and CBD businesses in the UK are asking the public to participate in the